Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Palau Pharma has developed a small molecule H4 receptor antagonist that is about to enter Phase I clinical trials for the treatment of allergic rhinitis and asthma. More
Kortos® Cream contains anti-inflammatory-antipruritic-vasoconstrictor, astringent, antiseptic and local anesthetic in a special water repellant base. More
All rights reserved. Terms and Conditions | Contact us
